Expertise in
5
conditions

Dr. David P. Roberge

Radiation Oncology
Office
262 Danny Thomas Pl # 515, 
Memphis, TN 
Expertise in
5
conditions
Office
262 Danny Thomas Pl # 515, 
Memphis, TN 

Overview

David Roberge is a Radiation Oncologist practicing medicine in Memphis, Tennessee.

Dr. Roberge is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Lung Cancer, Adult Soft Tissue Sarcoma, Non-Small Cell Lung Cancer (NSCLC), and Liver Embolization.

He is actively involved in clinical research, co-authoring 135 peer reviewed articles and participating in 5 clinical trials.

Specialties

Radiation Oncology

Licenses

Radiology in TN

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
262 Danny Thomas Pl # 515, Memphis, TN 38105
Other Locations
Canton-Potsdam Hospital
50 Leroy St, Potsdam, NY 13676

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Radiation, Procedure, Other
Study Phase: Phase 3
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
A Phase II, Multi-Centre Study, of Stereotactic Radiotherapy for Oligo-Progression in Metastatic Renal Cell Cancer Patients Receiving 1st Line Sunitinib Therapy
A Phase II, Multi-Centre Study, of Stereotactic Radiotherapy for Oligo-Progression in Metastatic Renal Cell Cancer Patients Receiving 1st Line Sunitinib Therapy
Enrollment Status: Completed
Publish Date: March 23, 2021
Intervention Type: Radiation
Study Phase: Phase 2
View 4 Less Clinical Trials

134 Total Publications

Modeling of the Alpha DaRT coated source using GEANT4: Investigating nuclei effective desorption probabilities, leakage process, and fractions of diffused nuclei.
Modeling of the Alpha DaRT coated source using GEANT4: Investigating nuclei effective desorption probabilities, leakage process, and fractions of diffused nuclei.
Journal: Biomedical physics & engineering express
Published: June 09, 2026
Similar Doctors
Expertise in
18
conditions
Dr. Thomas E. Merchant
Radiation Oncology
Expertise in
18
conditions
Dr. Thomas E. Merchant
Radiation Oncology
Referral may be required

St. Jude Children's Research Hospital

262 Danny Thomas Pl, 
Memphis, TN 
 (0.2 miles away)
901-595-3604
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Thomas Merchant is a Radiation Oncologist practicing medicine in Memphis, Tennessee. Dr. Merchant is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Craniopharyngioma, Ependymoma, Medulloblastoma, and Brain Tumor. Dr. Merchant is currently accepting new patients.

Expertise in
13
conditions
Dr. Matthew J. Krasin
Radiation Oncology
Expertise in
13
conditions
Dr. Matthew J. Krasin
Radiation Oncology
Referral may be required

St. Jude Children's Research Hospital

262 Danny Thomas Pl, 
Memphis, TN 
 (0.2 miles away)
901-595-3226
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew Krasin is a Radiation Oncologist practicing medicine in Memphis, Tennessee. Dr. Krasin is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Embryonal Tumor with Multilayered Rosettes, Nephrectomy, and Thrombectomy. Dr. Krasin is currently accepting new patients.

Expertise in
12
conditions
Dr. Derek S. Tsang
Radiation Oncology
Expertise in
12
conditions
Dr. Derek S. Tsang
Radiation Oncology
Referral may be required

St. Jude Children's Research Hospital

262 Danny Thomas Pl, 
Memphis, TN 
 (0.2 miles away)
901-595-3604
Languages Spoken:
English

Derek Tsang is a Radiation Oncologist practicing medicine in Memphis, Tennessee. Dr. Tsang is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Radiation Induced Meningioma, Brain Tumor, Ependymoma, Gamma Knife Radiosurgery, and Awake Craniotomy.

Frequently Asked Questions about Dr. David P. Roberge

How do I make an appointment with Dr. David P. Roberge?

You can book an appointment with Dr. David P. Roberge by calling their office at 315-261-5890. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David P. Roberge a top-rated expert for Brain Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David P. Roberge is classified as an Advanced expert for Brain Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David P. Roberge specialize in?

While Dr. David P. Roberge is a Radiation Oncology, they have specific expertise in Brain Tumor, Lung Cancer, and Adult Soft Tissue Sarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. David P. Roberge participate in research or clinical trials?

Yes. Dr. David P. Roberge has published 134 articles and abstracts on conditions like Brain Tumor. You can view a list of Dr. David P. Roberge's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Roberge's expertise for a condition
ConditionClose
      View All 26 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile